anonymous
Guest
anonymous
Guest
Oh, Karen
Enough with the Karen crap OK?
It was old a year ago dick.
Oh, Karen
What do you hate about working here?? Our salaries over $100k? Bonus? Car? So many reps out jobs and your complaining!!
I enjoy it, it can be challenging at times. We are gaining more favorable perceptions with outcomes data, and it’s helping drive more business. This is never going to be a Lipitor, but there is plenty of room for expanded usage now that patients are more brand aware thanks to NASCAR, and physicians comfort and confidence levels increase. This is not a good fit for people who want to go out and “represent” a product, it must be sold through strong clinical knowledge, confidence and conviction.Get back in your cubicle you Ann Arbor hack!! This place blows!! Try spending a day in the field sometime.
I enjoy it, it can be challenging at times. We are gaining more favorable perceptions with outcomes data, and it’s helping drive more business. This is never going to be a Lipitor, but there is plenty of room for expanded usage now that patients are more brand aware thanks to NASCAR, and physicians comfort and confidence levels increase. This is not a good fit for people who want to go out and “represent” a product, it must be sold through strong clinical knowledge, confidence and conviction.
You’re angry, Karen. Looks like you had another lonely holiday.Yep the NASCAR rednecks are bearing the doctor offices door down. The Circle Tracking Crowd are nothing but a pimple on the ass of lipid therapy. No office has seen strong clinical knowledge and selling skills. The office I work in laugh at the Esperion clown who comes in bragging how the race car did in a race I've never heard. As for the data nobody was impressed as the stock price reflected this when results came out. Thankfully your co- market with DS is going to wither away when you lose your court case. This is a company of losers!
Sorry, K-RonEnough with the Karen crap OK?
It was old a year ago dick.
So was your whining because you were not hired, p**sy.Enough with the Karen crap OK?
It was old a year ago dick.
Yep the NASCAR rednecks are bearing the doctor offices door down. The Circle Tracking Crowd are nothing but a pimple on the ass of lipid therapy. No office has seen strong clinical knowledge and selling skills. The office I work in laugh at the Esperion clown who comes in bragging how the race car did in a race I've never heard. As for the data nobody was impressed as the stock price reflected this when results came out. Thankfully your co- market with DS is going to wither away when you lose your court case. This is a company of losers!
Thanks, Karen Earnhardt.Yes. The Race Car marketing was brilliant. Lol
Thanks, Karen Earnhardt.
Enough with the Karen crap OK?
It was old a year ago dick.
Thanks for your input. Keep throwing your internet tantrums because you weren’t hired, Karen.Exactly.
But the Moron likes to amuse himself.
Stop messing around on here. I’m sure there’s a School Board meeting you are protesting today.Exactly.
But the Moron likes to amuse himself.
I’m in the process right now and it seems like it could be a pretty good opportunity, I’m just not sure exactly how they’re going to proceed forward. The information I’ve gotten thus far has been a bit vague, interviews have gone well, but I’ve not been able to pin down much info on how the process forward looks and the timelines. Does anyone else have any insight?
Stop messing around on here. I’m sure there’s a School Board meeting you are protesting today.
Thanks for your input. Keep throwing your internet tantrums because you weren’t hired, Karen.
More of your finance and scientific pontifications, please, Karen. What are your PTRS projections for tafolecimab and its impact on the non-FH market 10-yr CAGR based upon the phase 3 trial outcomes? Should any organization look at a licensing deal or perhaps acquire the asset? Can you get us a dossier from one of your HEOR connections? What were the endpoints that drove HTA to cover it or even the MOH in Brazil? That would help with CMS and peri-launch access strategy. Please share, Karen. Your basic business administration stock trading tips have been gold.You are welcome for thanking me for my input.
No need to get negative.
Karen label.
Shop worn.
Anything else ?